DSIP Dosage Chart: Research Dosing, Routes, and Timing

A DSIP dosage chart is a research reference that summarizes typical amounts of delta sleep-inducing peptide used in laboratory and clinical studies, along with the route and timing of administration. Most published protocols describe 100 to 300 micrograms (mcg) per subcutaneous injection before bed, while intranasal research often uses 100 to 500 mcg. DSIP is not FDA-approved for human use in the United States, so any chart is for educational and research purposes only.

Researchers and vendors often publish a dsip dosage chart to standardize how the peptide is measured, reconstituted, and timed. The numbers below reflect common ranges in the literature, not a medical recommendation. Anyone considering DSIP for sleep should speak with a licensed healthcare professional first.

What a DSIP Dosage Chart Actually Shows

Delta sleep-inducing peptide is a nonapeptide first isolated from rabbit brains in the 1970s. Early studies explored its effects on sleep architecture, pain, and stress response. Because those studies used different routes, solvents, and endpoints, the dose ranges varied widely.

A useful DSIP chart typically includes four columns: route of administration, typical research dose, frequency, and timing. Some charts also note the vial size and the amount of bacteriostatic water used for reconstitution. Without those details, a dose number alone is not very meaningful.

• Subcutaneous (SC): the most cited route, usually 100–300 mcg per injection.
• Intranasal: often 100–500 mcg per spray or series of sprays.
• Intramuscular (IM): less common, sometimes 200–500 mcg.
• Timing: typically 30–60 minutes before sleep.

Published human studies are old and small by modern standards. That is why most current DSIP discussion happens in research-chemical communities rather than clinical guidelines. No standard adult dose has been established by the FDA or any major medical body.

DSIP Dosage Chart by Route

The table below organizes the most frequently cited DSIP research ranges. Treat every number as a starting point for reading the literature, not as a personal prescription.

Route	Typical research dose	Frequency	Timing
Subcutaneous	100–300 mcg	Once daily	30–60 min before bed
Intranasal	100–500 mcg	Once daily	20–30 min before bed
Intramuscular	200–500 mcg	Once daily	30–60 min before bed
Intravenous (research only)	25–100 mcg	Single dose in studies	Varies by protocol

Subcutaneous injection is the most common route in the literature because absorption is predictable and the peptide is small enough to pass into circulation. Intranasal use has gained popularity because it avoids needles, but nasal absorption can be inconsistent. Intramuscular and intravenous routes appear mostly in older academic work.

Some researchers split the daily amount into two smaller doses, but there is no strong evidence that split dosing works better. A single pre-sleep dose is the pattern most charts reflect.

Reconstitution Math for DSIP 5mg and 10mg Vials

Most DSIP arrives as a lyophilized powder in a 5 mg or 10 mg vial. Before any dosing chart makes sense, the powder must be reconstituted with bacteriostatic water or sterile water. The concentration you create determines how much liquid equals a given dose.

For a 5 mg vial, adding 1 mL of water yields 5 mg/mL. In that case, a dsip 5mg dosage of 100 mcg equals 0.02 mL, or 2 units on a standard U-100 insulin syringe. Adding 2 mL instead yields 2.5 mg/mL, so 100 mcg equals 0.04 mL, or 4 units.

For a 10 mg vial, the same logic applies. Adding 2 mL gives 5 mg/mL, and adding 1 mL gives 10 mg/mL. A 10 mg vial often lasts longer, but higher concentration means smaller, harder-to-measure volumes for low doses.

A dsip dosage calculator can remove some of the arithmetic risk, especially when switching between vial sizes or syringe types. Even with a calculator, double-check the units: micrograms and milligrams are easily confused, and a 1,000-fold error is dangerous.

DSIP Nasal Spray Dosage and Other Routes

Intranasal delivery is popular because it is needle-free, but the dosage picture is less standardized. A typical dsip nasal spray dosage in research discussions falls between 100 mcg and 500 mcg per day, usually taken in the evening.

Nasal spray concentration depends on how the peptide is mixed. Some users prepare a solution with 1–5 mg of DSIP per mL of saline or sterile water. That means each spray delivers a different amount depending on the sprayer, the volume per spray, and how many sprays are used.

Because nasal absorption varies from person to person, intranasal DSIP is harder to dose precisely than subcutaneous injection. Researchers who need exact amounts usually prefer injection for that reason. Anyone using a nasal spray should still measure the liquid carefully and document each batch.

DSIP Dosage Cycle: Length and Timing

DSIP is often discussed as a short-term research peptide rather than a daily lifelong supplement. A common dsip dosage cycle in online protocols runs 2 to 4 weeks, followed by a break of equal or greater length. No controlled trial has validated that schedule.

Timing matters because DSIP is linked to sleep onset. Most charts place the dose 30 to 60 minutes before bed. Taking it earlier in the day is uncommon in the literature and may not match the peptide’s natural rhythm.

• Start low: many researchers begin at the bottom of the range, such as 100 mcg SC.
• Track sleep: keep a simple log of sleep latency, wake-ups, and morning grogginess.
• Cycle off: use a break period to see whether effects persist without the peptide.
• Avoid stacking: combining DSIP with sedatives, alcohol, or other sleep aids increases uncertainty.

There is no established maximum dose, and more is not necessarily better. Some early studies used very low microgram amounts, which suggests that higher doses are not automatically more effective.

How DSIP Compares to Other Research Peptides

DSIP is often sold alongside other research peptides, but their dosing charts are not interchangeable. For example, a mots-c dosage chart typically lists 5–10 mg per week for metabolic research, which is far larger than any DSIP range. Body-protection peptides like BPC-157 are usually measured in micrograms too, but they are studied for tissue repair rather than sleep.

Peptide	Typical research range	Common route	Primary research focus
DSIP	100–500 mcg per day	Subcutaneous or intranasal	Sleep architecture, stress response
MOTS-c	5–10 mg per week	Subcutaneous	Metabolic regulation, exercise mimicry
BPC-157	250–500 mcg per day	Subcutaneous or oral	Tissue repair, gut lining
Lipo-C	0.5–1 mL per injection	Subcutaneous	Fat metabolism (blend)

Comparing charts side by side shows why units matter. A 5 mg MOTS-c dose is 10 to 50 times larger than a typical DSIP dose. Anyone who assumes all peptide charts use the same scale could make a serious measurement error.

If you are researching multiple peptides, keep separate notes and separate syringes. A DSIP chart will not translate to another compound because the research goals and dose ranges are different.

Safety, Legality, and Medical Guidance

DSIP is not approved by the FDA for human use, and it is not a scheduled controlled substance. It is generally sold as a research chemical, which means it is not regulated for purity, sterility, or human dosing. Buying or possessing it for personal use sits in a legal gray area that varies by state.

Reported side effects in early studies were mild and uncommon, but the data are limited. Possible issues include headache, nausea, dizziness, and next-day drowsiness. Injecting any non-pharmaceutical powder carries risks of infection, allergic reaction, and dosing errors.

• Never use DSIP to replace a prescribed sleep treatment.
• Talk to a doctor or pharmacist before combining it with any medication.
• Store lyophilized vials in the refrigerator or freezer, protected from light.
• Discard reconstituted peptide if it looks cloudy or contains particles.

A dosage chart is a reading aid, not medical advice. The safest choice for sleep problems is a licensed clinician who can evaluate causes and offer evidence-based options.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical DSIP dosage for sleep research?

Most published DSIP research uses 100 to 300 mcg subcutaneously or 100 to 500 mcg intranasally, taken 30 to 60 minutes before bed. These are historical research ranges, not FDA-approved human doses. DSIP has not been proven safe or effective for treating insomnia.

How do I calculate DSIP dosage from a 5 mg vial?

Add 1 mL of bacteriostatic water for a 5 mg/mL concentration, or 2 mL for 2.5 mg/mL. At 5 mg/mL, a 100 mcg dose is 0.02 mL, which equals 2 units on a U-100 insulin syringe. At 2.5 mg/mL, the same dose is 0.04 mL, or 4 units.

Is DSIP legal to buy in the United States?

DSIP is not FDA-approved for human use and is typically sold as a research chemical. It is not a controlled substance under federal law, but state laws and vendor policies vary. Buying it for personal human consumption is not legal under FDA rules.